SEC Form D · filed January 10, 2018
Kv1.3 Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Craig Philips · Seattle, WAExecRobert Hedequist · Seattle, WADirectorLucien Fouke · Seattle, WADirectorShawn Iadonato · Seattle, WADirectorGavin Jancke · SEATTLE, WADirectorDaniel Raymond · Seattle, WADirectorDaniel J. Tasse · San Francisco, CADirectorLord Farmer · LONDON, United KingdomDirectorRichard J. Nesbit · San Francisco, CADirectorRon W. Pauli · San Francisco, CADirectorLlew J. Keltner · San Francisco, CADirectorPaul G. Coughlan · London, United KingdomExecJoshua W. Kriesel · San Francisco, CADirectorStephen F. Mahedy · Beltsville, MDExecMichael Hanrahan · Downers Grove, ILDirectorRichard W. Pascoe · Celebration, FLDirectorJoseph B. Saluri · Celebration, FLDirectorSven L. Guenther · Celebration, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗